C12N 2710/20033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/20033 (Use of viral protein as therapeutic agent other than vaccine) appears on 17 US grants and 28 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 28
- Assignees
- 19
- Inventors
- 49
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 3 |
| 2017 | 3 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 3 |
| 2022 | 0 | 4 |
| 2023 | 2 | 3 |
| 2024 | 2 | 2 |
| 2025 | 2 | 2 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cell capable of activating immune system, and pharmaceutical composition containing said cell11 Aug 2026US 12,703,867 B2Riken
- Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors20 Jan 2026US 12,528,839 B2Verimmune Inc.
- Structurally modified chimeric polypeptide of human papillomavirus, recombinant protein comprising same polypeptide, and use of same protein9 Sep 2025US 12,410,214 B2Genematrix Inc.
- CpG amphiphiles and uses thereof11 Mar 2025US 12,247,052 B2Elicio Therapeutics, Inc.
- Cell-penetrating peptides and methods of use thereof13 Aug 2024US 12,060,388 B2Yale University
- Cpg amphiphiles and uses thereof15 Jan 2026US 2026/0015390 A1Elicio Therapeutics, Inc.
- Cpg amphiphiles and uses thereof29 May 2025US 2025/0171507 A1Elicio Therapeutics, Inc.
- Multimeric T-Cell Modulatory Polypeptides and Methods of Use Thereof20 Mar 2025US 2025/0092113 A1Cue Biopharma, Inc.
- Cell-Penetrating Peptides and Methods of Use Thereof7 Nov 2024US 2024/0368229 A1Yale University
- Virus-like particle conjugates for diagnosis and treatment of tumors4 Jul 2024US 2024/0216527 A1Aura Biosciences, Inc.
Most cited
By later US patents
- Virus-like particle conjugates for diagnosis and treatment of tumors14US 10,117,947 B2Aura Biosciences, Inc. · 2018
- Methods for constructing antibiotic resistance free vaccines10US 8,906,664 B2The Trustees of the University of Pennsylvania · 2014
- Methods for constructing antibiotic resistance free vaccines10US 9,492,527 B2The Trustees of the University of Pennsylvania · 2016
- Methods for constructing antibiotic resistance free vaccines10US 9,700,608 B22017
- Virus-like particle conjugates for diagnosis and treatment of tumors4US 10,588,984 B2Aura Biosciences, Inc. · 2020